KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Current Leases (2021 - 2024)

Historic Current Leases for BioNTech SE (BNTX) over the last 4 years, with Q4 2024 value amounting to $42.2 million.

  • BioNTech SE's Current Leases rose 3960.98% to $42.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $42.2 million, marking a year-over-year increase of 3960.98%. This contributed to the annual value of $42.2 million for FY2024, which is 3960.98% up from last year.
  • Latest data reveals that BioNTech SE reported Current Leases of $42.2 million as of Q4 2024, which was up 3960.98% from $30.2 million recorded in Q4 2023.
  • BioNTech SE's 5-year Current Leases high stood at $42.2 million for Q4 2024, and its period low was $30.2 million during Q4 2023.
  • For the 4-year period, BioNTech SE's Current Leases averaged around $35.3 million, with its median value being $34.3 million (2022).
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 1768.36% in 2023, then surged by 3960.98% in 2024.
  • Over the past 4 years, BioNTech SE's Current Leases (Quarter) stood at $31.9 million in 2021, then rose by 15.08% to $36.7 million in 2022, then decreased by 17.68% to $30.2 million in 2023, then surged by 39.61% to $42.2 million in 2024.
  • Its last three reported values are $42.2 million in Q4 2024, $30.2 million for Q4 2023, and $36.7 million during Q4 2022.